Welcome to Zoladex.net,
an international educational resource for healthcare professionals with an interest in prostate cancer treatment, provided by AstraZeneca.
ZOLADEX is also used for the treatment of breast cancer, please visit ZOLADEX in breast cancer.
-
Features
-
Treating with ZOLADEX:
a section intended for healthcare providers including nurses and featuring the ZOLADEX SafeSystem
-
Living with ZOLADEX:
a section intended for healthcare providers including nurses, providing information for sharing with your patients
-
Multimedia Product Overview :
explaining efficacy, tolerability, dosage and much more using diagrams and voice
-
-
News
-
Nov 20, 2008
:
QoL of prostate cancer patients not accurately assessed by the FACT-P
-
Nov 19, 2008
:
Prostate cancer initiation linked to chromosome deletions
-
Nov 19, 2008
:
Androgen response element variant unrelated to prostate cancer
-
Nov 18, 2008
:
High-dose rate brachytherapy treats hematuria in prostate cancer
-
Nov 20, 2008
:
QoL of prostate cancer patients not accurately assessed by the FACT-P
Drug related information may refer to unlicensed products or uses, which may not be approved in your own country. Please consult your local prescribing information. No information provided on this site should be taken as a recommendation from this website or the site sponsors as to the use of any product.
This site is not intended for the following audiences who should use the links below:
US Citizens should visit ProstateInfo.com
UK Patients should visit AstraZeneca.co.uk
UK Physicians should visit CancerLineUK.net
Journalists should visit AstraZenecaPressOffice.com
Patients and carers (non US and non UK) should visit PatientHealthInternational.com.
Page tools
Please note
Features
Information for
This is an AstraZeneca International website for healthcare professionals. The site is not intended for the following audiences who should use the links below:
